Search

Displaying results 7961 - 7970 of 10000 in total
  1. Drug

    AB-207

    go.drugbank.com/drugs/DB22801
    Investigational

    AB-207 is under investigation in clinical trial NCT06456073 (E-CEL UVEC Treatment for Anal Fissures).

    Synonyms: E-CEL UVE, E-CEL UVEC cells
  2. Drug

    Indium

    go.drugbank.com/drugs/DB11659
    Investigational

    Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.

  3. Drug

    Safingol

    go.drugbank.com/drugs/DB11924
    Investigational

    Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  4. Drug

    Oleandrin

    go.drugbank.com/drugs/DB12843
    Investigational

    Oleandrin has been used in trials studying the treatment of Lung Cancer and Chemotherapeutic Agent Toxicity.

  5. Drug

    Alcuronium

    go.drugbank.com/drugs/DB13648
    Experimental

    It is used as an anesthesia adjuvant.

    Synonyms: N,N'-Diallylnortoxiferinium, N,N'-diallyl-bis-nor-toxiferine
  6. Drug

    Ceftiofur

    go.drugbank.com/drugs/DB11485
    ExperimentalVet approved

    E. coli strains resistant to ceftiofur have been reported. … Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine.

  7. Drug

    Galicaftor

    go.drugbank.com/drugs/DB14894
    Investigational

    in Patients With Cystic Fibrosis.). … Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737

  8. Drug

    Edodekin alfa

    go.drugbank.com/drugs/DB15631
    Investigational

    Edodekin alfa is under investigation in clinical trial NCT01468896 (Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That Is Recurrent, Metastatic

  9. Drug

    Nanoparticle Epirubicin

    go.drugbank.com/drugs/DB16248
    Investigational

    Nanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma).

  10. Drug

    KER-047

    go.drugbank.com/drugs/DB19111
    Investigational

    KER-047 is under investigation in clinical trial NCT05927012 (A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (